For comparison of effectiveness, the serum marker SCC, which is the best studied serum marker for squamous cell carcinomas, is elevated in only 22–60% of early-stage cervical squamous cell carcinomas [2,3]. This evidence concerns the gene SERPINB3 and cervical squamous cell carcinoma.